Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Rhogef17: A novel target for endothelial barrier function
oleh: Zhuolin Wu, Quanlei Liu, Yan Zhao, Chaonan Fang, Wen Zheng, Zilin Zhao, Nai Zhang, Xinyu Yang
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2024-01-01 |
Deskripsi
ARHGEF17 encodes the protein RhoGEF17, which is highly expressed in vascular endothelial cells. It is a guanine nucleotide exchange factor (GEF) that accelerates the exchange of GDP with GTP on many small GTPases through its Dbl homology (DH) domain, enabling the activation of Rho-GTPases such as RhoA, RhoB, and RhoC. Rho GTPase-regulated changes in the actin cytoskeleton and cell adhesion kinetics are the main mechanisms mediating many endothelial cell (EC) alterations, including cell morphology, migration, and division changes, which profoundly affect EC barrier function. This review focuses on ARHGEF17 expression, activation and biological functions in ECs, linking its regulation of cellular morphology, migration, mitosis and other cellular behaviors to disease onset and progression. Understanding ARHGEF17 mechanisms of action will contribute to the design of therapeutic approaches targeting RhoGEF17, a potential drug target for the treatment of various endothelium-related diseases, Such as vascular inflammation, carcinogenesis and transendothelial metastasis of tumors.